PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0GEA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $326,907
Award facts
- Contract value 100% obligated
- $326,907.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $326,907.30, was awarded on May 26, 2025, to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery under a firm fixed-price arrangement. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contracting agency is the Defense Logistics Agency's Medical Supply Chain division. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. This non-competitive delivery order continues AmerisourceBergen's role as a prime pharmaceutical vendor supplying critical medical commodities, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare products to support military and federal healthcare systems.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, maintains an extensive portfolio of federal medical procurement contracts supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards consistently demonstrate capability to deliver a comprehensive range of therapeutic products spanning diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies through competitive procurement processes. This delivery order is expected to reach ultimate completion by May 27, 2025, and represents continued execution under the strategic global pharmaceutical support vehicle that enables AmerisourceBergen to fulfill diverse federal medical supply requirements across multiple service branches and agencies.
Quick answers
Who was awarded contract SPE2D825F0GEA?
SPE2D825F0GEA was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 26, 2025.
How much is contract SPE2D825F0GEA worth?
The government has obligated $326,907 on SPE2D825F0GEA.
Is contract SPE2D825F0GEA an order under another contract?
Yes. SPE2D825F0GEA is a delivery order under SPE2DX22D0059, an indefinite delivery contract.
Was contract SPE2D825F0GEA competed?
The extent of competition for SPE2D825F0GEA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award